TNF and breast cancer: Evaluated parameters included tumor incidence, tumor mass and volume, histopathology, breast cancer biomarker CA 15–3, antioxidant status (CAT, GSH, MDA, NO, SOD), TNF-α and INFγ levels, lipid profile (total cholesterol, LDL-cholesterol, triglycerides and HDL-cholesterol), as well as toxicity parameters (ALT, AST, creatinine).